BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 26387962)

  • 1. Observed-to-expected ratio for adherence to treatment guidelines as a quality of care indicator for ovarian cancer.
    Galvan-Turner VB; Chang J; Ziogas A; Bristow RE
    Gynecol Oncol; 2015 Dec; 139(3):495-9. PubMed ID: 26387962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of National Cancer Institute Comprehensive Cancer Centers on ovarian cancer treatment and survival.
    Bristow RE; Chang J; Ziogas A; Campos B; Chavez LR; Anton-Culver H
    J Am Coll Surg; 2015 May; 220(5):940-50. PubMed ID: 25840536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Observed-to-expected ratio for adherence to treatment guidelines as a quality of care indicator for laryngeal cancer.
    Swegal WC; Herbert RJ; Eisele DW; Chang J; Bristow RE; Gourin CG
    Laryngoscope; 2020 Mar; 130(3):672-678. PubMed ID: 31169916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Risk-Adjusted Model for Ovarian Cancer Care and Disparities in Access to High-Performing Hospitals.
    Bristow RE; Chang J; Villanueva C; Ziogas A; Vieira VM
    Obstet Gynecol; 2020 Feb; 135(2):328-339. PubMed ID: 31923082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adherence to treatment guidelines for ovarian cancer as a measure of quality care.
    Bristow RE; Chang J; Ziogas A; Anton-Culver H
    Obstet Gynecol; 2013 Jun; 121(6):1226-1234. PubMed ID: 23812456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sociodemographic disparities in advanced ovarian cancer survival and adherence to treatment guidelines.
    Bristow RE; Chang J; Ziogas A; Campos B; Chavez LR; Anton-Culver H
    Obstet Gynecol; 2015 Apr; 125(4):833-842. PubMed ID: 25751200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of provider volume on front-line chemotherapy guideline compliance and overall survival in elderly patients with advanced ovarian cancer.
    Aviki EM; Lavery JA; Roche KL; Cowan R; Dessources K; Basaran D; Green AK; Aghajanian CA; O'Cearbhaill R; Jewell EL; Leitao MM; Gardner GJ; Abu-Rustum NR; Sabbatini P; Bach PB
    Gynecol Oncol; 2020 Nov; 159(2):418-425. PubMed ID: 32814642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of hospital myocardial infarction volume with adherence to American College of Cardiology/American Heart Association performance measures: Insights from the National Cardiovascular Data Registry.
    Harrison RW; Simon D; Miller AL; de Lemos JA; Peterson ED; Wang TY
    Am Heart J; 2016 Aug; 178():95-101. PubMed ID: 27502856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spatial analysis of advanced-stage ovarian cancer mortality in California.
    Bristow RE; Chang J; Ziogas A; Gillen DL; Bai L; Vieira VM
    Am J Obstet Gynecol; 2015 Jul; 213(1):43.e1-43.e8. PubMed ID: 25644440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Socioeconomic status as a predictor of adherence to treatment guidelines for early-stage ovarian cancer.
    Hodeib M; Chang J; Liu F; Ziogas A; Dilley S; Randall LM; Anton-Culver H; Bristow RE
    Gynecol Oncol; 2015 Jul; 138(1):121-7. PubMed ID: 25913132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of race, socioeconomic status, and the health care system on the treatment of advanced-stage ovarian cancer in California.
    Long B; Chang J; Ziogas A; Tewari KS; Anton-Culver H; Bristow RE
    Am J Obstet Gynecol; 2015 Apr; 212(4):468.e1-9. PubMed ID: 25448522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spatial analysis of adherence to treatment guidelines for advanced-stage ovarian cancer and the impact of race and socioeconomic status.
    Bristow RE; Chang J; Ziogas A; Anton-Culver H; Vieira VM
    Gynecol Oncol; 2014 Jul; 134(1):60-7. PubMed ID: 24680770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disparities in ovarian cancer care quality and survival according to race and socioeconomic status.
    Bristow RE; Powell MA; Al-Hammadi N; Chen L; Miller JP; Roland PY; Mutch DG; Cliby WA
    J Natl Cancer Inst; 2013 Jun; 105(11):823-32. PubMed ID: 23539755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Hospital Volume With Racial and Ethnic Disparities in Locally Advanced Cervical Cancer Treatment.
    Uppal S; Chapman C; Spencer RJ; Jolly S; Maturen K; Rauh-Hain JA; delCarmen MG; Rice LW
    Obstet Gynecol; 2017 Feb; 129(2):295-304. PubMed ID: 28079775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association Between Hospital Volume, Processes of Care, and Outcomes in Patients Admitted With Heart Failure: Insights From Get With The Guidelines-Heart Failure.
    Kumbhani DJ; Fonarow GC; Heidenreich PA; Schulte PJ; Lu D; Hernandez A; Yancy C; Bhatt DL
    Circulation; 2018 Apr; 137(16):1661-1670. PubMed ID: 29378692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-term survival analysis of a risk-adjusted model for ovarian cancer care.
    Hari A; Chang J; Villanueva C; Ziogas A; Vieira V; Bristow RE
    Gynecol Oncol; 2024 Feb; 184():123-131. PubMed ID: 38309029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of hospital volume on surgical management and outcomes for early-stage cervical cancer.
    Aviki EM; Chen L; Dessources K; Leitao MM; Wright JD
    Gynecol Oncol; 2020 May; 157(2):508-513. PubMed ID: 32089335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adherence to treatment guidelines as a major determinant of survival disparities between black and white patients with ovarian cancer.
    Chen F; Bailey CE; Alvarez RD; Shu XO; Zheng W
    Gynecol Oncol; 2021 Jan; 160(1):10-15. PubMed ID: 33208254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hospital Readmission as a Poor Measure of Quality in Ovarian Cancer Surgery.
    Uppal S; Spencer RJ; Rice LW; Del Carmen MG; Reynolds RK; Griggs JJ
    Obstet Gynecol; 2018 Jul; 132(1):126-136. PubMed ID: 29889756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-volume ovarian cancer care: survival impact and disparities in access for advanced-stage disease.
    Bristow RE; Chang J; Ziogas A; Randall LM; Anton-Culver H
    Gynecol Oncol; 2014 Feb; 132(2):403-10. PubMed ID: 24361578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.